- Open Access
Diarrhea in young children from low-income countries leads to large-scale alterations in intestinal microbiota composition
Genome Biology volume 15, Article number: R76 (2014)
Diarrheal diseases continue to contribute significantly to morbidity and mortality in infants and young children in developing countries. There is an urgent need to better understand the contributions of novel, potentially uncultured, diarrheal pathogens to severe diarrheal disease, as well as distortions in normal gut microbiota composition that might facilitate severe disease.
We use high throughput 16S rRNA gene sequencing to compare fecal microbiota composition in children under five years of age who have been diagnosed with moderate to severe diarrhea (MSD) with the microbiota from diarrhea-free controls. Our study includes 992 children from four low-income countries in West and East Africa, and Southeast Asia. Known pathogens, as well as bacteria currently not considered as important diarrhea-causing pathogens, are positively associated with MSD, and these include Escherichia/Shigella, and Granulicatella species, and Streptococcus mitis/pneumoniae groups. In both cases and controls, there tend to be distinct negative correlations between facultative anaerobic lineages and obligate anaerobic lineages. Overall genus-level microbiota composition exhibit a shift in controls from low to high levels of Prevotella and in MSD cases from high to low levels of Escherichia/Shigella in younger versus older children; however, there was significant variation among many genera by both site and age.
Our findings expand the current understanding of microbiota-associated diarrhea pathogenicity in young children from developing countries. Our findings are necessarily based on correlative analyses and must be further validated through epidemiological and molecular techniques.
Diarrheal diseases continue to be major causes of childhood mortality, ranking among the top four largest contributors to years of life lost in sub-Saharan Africa and South Asia . The proportion of deaths attributed to diarrhea among children aged under 5 years is estimated to be approximately 15% worldwide , and as high as approximately 25% in Africa and 31% in South East Asia . More than two dozen enteric pathogens, belonging to diverse branches of the tree of life, are known to cause diarrhea and can be tested for in a clinical setting. However, it is likely that additional pathogens remain to be identified among the enteric microbiota.
In response to important unanswered questions surrounding the burden and etiology of childhood diarrhea in developing countries, the William and Melinda Gates Foundation commissioned the Global Enterics Multicenter Study (GEMS) , which recently reported the pathogens responsible for cases of moderate-to-severe diarrhea (MSD) in seven impoverished countries of sub-Saharan Africa and south Asia. Importantly, for approximately 60% of MSD cases in GEMS, no known pathogen could be implicated by conventional diagnostic methods . These observations highlight the potential presence of previously undiscovered pathogens, and/or possible interactions between pathogens and other members of the intestinal microbiota (both pathogenic and commensal) that may either exacerbate the clinical manifestation or protect the host from disease.
Here we apply molecular techniques to survey the intestinal microbiota in a subset of GEMS cases and controls. Our study comprises 992 children from four under-developed countries in West Africa (The Gambia and Mali), East Africa (Kenya), and South Asia (Bangladesh), representing a subset of the over 25,000 GEMS children enrolled. Our results shed additional light on potential mechanisms underlying MSD in children of developing countries. Prior to presenting these results we would like to stress that our analyses are, by necessity, correlative and the results presented here must be validated through epidemiological and molecular analyses, several of which are already underway.
Results and discussion
Description of data
Our data comprise roughly equal proportions of cases and controls (0.51 vs. 0.49, respectively) from four sites: Bangladesh (N = 206), The Gambia (N = 269), Kenya (N = 305), and Mali (N = 212). Approximately 55% of the subjects were boys. Of 992 samples, 508 were from patients with MSD (Table 1). The children ranged in age from newborn to 59 months. We stratified them into five age categories: 0 to 5 months (N = 112), 6 to 11 months (N = 308), 12 to 17 months (N = 173), 18 to 23 months (N = 146), and 24 to 59 months (N = 253). There were no significant differences between the proportion of cases and controls in each country and from each age group (Table 1). The sequencing of PCR amplified 16S rRNA genes resulted in 3,584,096 reads passing quality checks. Each sample had at least 1,000 reads, and there were an average of 3,613 reads per sample. The reads were clustered using DNAclust  into 97,666 operational taxonomic units (OTUs). Of these, 21,247 passed chimera checking, were detected in more than five samples, or represented at least 20 sequences in a single sample, and were included in further analysis. The number of OTUs per sample ranged from 55 to 1252, with a median of 380 and an average of 412. The mean OTU size was 138, ranging from 5 (by definition) to 192,978 (with median OTU size = 15 sequences). Representative sequences from the 21,247 OTUs matched 728 distinct taxa from 161 genera. Among these, 4,730 (22 %) did not have good (>100 bp exact match, >97% identity) matches to isolate sequences from the Ribosomal Database Project (RDP). These were flagged as ‘unassigned’ in our analysis and are discussed further below. These sequences are not simply an artifact of our stringent alignment criteria as evidenced by the fact that a re-analysis of the 6,879 most abundant OTUs using the reference-based OTU picking algorithm implemented in Qiime  failed to classify a similar proportion of sequences (2,162 or 31% of the abundant OTUs).
Microbiota variations by age
The well documented [8–10] succession of the intestinal microbiota during child development is apparent in our non-diarrheal control samples (Figure 1A). During the first year of life, the ‘healthy’ gut microbiota in our infant cohorts is characterized by comparatively low overall diversity and a relatively high proportion of facultatively anaerobic, and potentially pathogenic, organisms (for example, the Escherichia/Shigella group, which cannot be distinguished from each other by 16S rRNA gene sequences), organisms that are believed to play a role in the development of the host immune system [11, 12]. In older ages, the dominance of these organisms is reduced, replaced by a corresponding increase in overall diversity (Figure 1B), accompanied by a particularly pronounced increase in the proportional abundance of the bacterial genus Prevotella. These changes are most evident in our non-diarrheal control samples, where the genus Prevotella increases from approximately 12% to approximately 48% proportional abundance during the first 5 years of life, while the Escherichia genus drops from about 20% proportional abundance in infants under 6 months of age to approximately 1% in 2- to 5-year-olds (Additional file 1: Table S1). Two other genera, Veillonella and Streptococcus also exhibit significant decreases with increasing age. Our data also show an increase with increasing age in the proportion of a range of organisms (labeled ‘unassigned’ in Figure 1A and Additional file 1: Table S1) that have no good quality matches to cultured isolates in public databases, and which appear to belong predominantly to obligate anaerobic bacteria (over 60% can be assigned by the RDP classifier to the Ruminococcaceae and Lachnospiraceae families of the Firmicutes phylum, which are relatively poorly represented in culture collections , as well as the Bacteroidaceae family). These previously-uncultured putative obligate anaerobes increase in proportional abundance from approximately 8% in diarrhea-free young children to approximately 23% in the older age group, consistent with increase in diversity within the intestinal microbiota and the known expansion of these groups, which are able to colonize the intestine in greater numbers as the complex polysaccharides they utilize for growth become a greater feature of the host diet .
These observations broadly hold when stratifying by country of origin; however, country-specific effects are also apparent. For example, the samples from Bangladesh are different from the African countries, particularly in the younger age groups, and are characterized by a lower proportion of Prevotella sequences and a higher proportion of organisms from the Escherichia/Shigella and Streptococcus genera (Figure 1A and Additional file 1: Table S1).
The patterns observed within control samples were significantly different from patterns from patients with MSD; however, some overall age-related trends were similar. For example, Prevotella abundance correlates with age, albeit reaching a much lower peak, with only 23% abundance in the oldest age group (vs. 48% in controls, P <10-16). Other obligate anaerobic microbes have lower proportional abundance among cases compared to controls: Bacteroides and the unclassified putative anaerobes are both 5% lower in cases, consistent with previous observations that indicate intestinal dysbiosis is associated with a decrease in the proportional abundance of obligate anaerobes . Among cases, Escherichia/Shigella and Streptococcus spp. maintain a high proportion across all age groups, though their preponderance drops significantly (41% to 13% and 18.5% to 7.5%, respectively) as children age. Furthermore it appears that Prevotella and Escherichia/Shigella are negatively correlated in MSD cases (Spearman rho = -0.55, P <0.0001). The disruption associated with diarrhea is also reflected in lower diversity values in MSD cases in every age group (Figure 1B, Additional file 2: Table S2, Additional file 3: Figures S1A-D).
Country-specific effects were also observed in diarrheal stool; for instance, in Kenya, diarrhea appeared to have a less marked effect on the microbiota (Figure 1A and Additional file 1: Table S1). Escherichia/Shigella spp. were most common in Mali, accounting for 34% of the sequences, next most common in Bangladesh (24%) and least common in The Gambia (15%). Prevotella spp. were found in high proportional abundances in The Gambia (18%) and Kenya (19%). The genus Streptococcus is found in relatively high abundances in Bangladesh (21%) and The Gambia (13%) with lower abundances in Mali (10%) and Kenya (9%). As expected, the taxonomic diversity (Shannon diversity index) is significantly different between cases and controls in all countries (P <0.005, pairwise t-test). Of note, where Prevotella is more common (The Gambia and Kenya), the diversity is higher (Figure 1B).
Taxonomic groups statistically increased or decreased in diarrhea
Multidimensional scaling analysis could not separate the diarrhea and diarrhea-free bacterial communities due to high inter-personal variation (Additional file 3: Figure S3). We estimated the association of individual OTUs with disease using statistical tests addressing both presence-absence statistics (Fisher’s exact test and logistic regression) and abundance-dependent statistics (using generalized linear models) that account for the number of OTU-specific sequences in each stool, and potential confounders such as sampling depth, age, and country (see Additional file 4: Table S3 for a full summary). The former address similar questions to those commonly targeted by the traditional culture-based epidemiological studies, while the latter allow us to assess how pathogen proportional abundance correlates with morbidity.
Ten OTUs were found to be positively associated with diarrhea by all statistical tests. The OTUs associated with MSD have high-similarity matches against database sequences from bacterial taxa in the Escherichia/Shigella, Granulicatella spp., and Streptococcus mitis/pneumoniae groups. When only abundance-dependent statistics are used to determine significance, an additional 18 OTUs are found to be highly associated with diarrhea, corresponding to the bacterial species Escherichia/Shigella, Campylobacter jejuni, and Streptococcus pasteurianus. When only considering presence/absence statistics, 43 additional OTUs are found to be associated with diarrhea, comprising the bacterial groups already discussed above as well as members of the genera Lactobacillus, Neisseria, Citrobacter, Erwinia, and Haemophilus. It is noteworthy that all of these organisms are either facultatively anaerobic or microaerophilic.
On the other hand, there were no OTUs positively associated with healthy stools by both statistical methods, reflecting the higher degree of inter-individual variation in microbiota content in healthy individuals. Considering only presence/absence statistics, there are 43 OTUs associated with non-diarrheal control samples. The genera associated with these control samples include members of the clostridial families Peptostreptococcaceae, Eubacteriaceae, and Erysipelotrichaceae, and the genera Clostridium sensu stricto, Dialister, Enterococcus, Prevotella, Ruminococcus, and Turicibacter. When considering only abundance statistics, an additional 19 OTUs are significantly associated with non-diarrhea samples and have high quality matches to database sequences corresponding to Bacteroides fragilis, Dialister, Megasphaera, Mitsuokella/Selenomonas, Prevotella spp., and Clostridium difficile. Thus, it can be seen that many obligate anaerobic bacterial lineages correlate with healthy status.
Functional differences between cases and controls
The broad statements made above about oxygen tolerance in the diseased microbiota are supported by PICRUST  analyses of our data. Specifically, this showed putative signatures of obligate anaerobic gut lineages to be enriched in the diarrhea-free samples (for example, glycolysis, P = 10-9; pyruvate metabolism, P = 10-7; short chain fatty acid biosynthesis, P = 10-3; xylene degradation, P = 10-7; and so on; all P values by Welch’s t-test as computed by STAMP ), while oxygen dependent pathways (for example, the TCA cycle, P <10-15) are enriched in diseased samples.
Taxonomic groups correlated with dysentery
We segregated diarrheal stool based on diagnosis of dysentery (presence of blood) and found a total of 30 OTUs that were strongly correlated with dysentery when comparing with non-dysentery diarrheal stool (metagenomeSeq , P <0.05). These include several well-known pathogens such as Enterococcus faecalis, Campylobacter jejuni, Bacteroides fragilis, Clostridium perfringens, Enterobacter cancerogenus, and members of the Granulicatella, Haemophilus, Klebsiella, and Escherichia/Shigella genera. Also associated with dysentery were members of the Streptococcus pasteurianus and Streptococcus salivarius groups. A single OTU, corresponding to Lactobacillus ruminis, was found to be negatively associated with dysentery. A genus-level representation of these findings is shown in Figure 2.
Network view of diarrheal illness
The overall results presented above are also borne out in correlation networks constructed from the data (Additional file 3: Figure S7). At the broad level, in both MSD cases and controls, it can be seen that there tend to be negative correlations between facultative anaerobic lineages and obligate anaerobic lineages. The most obvious example is the negative correlation of the potentially protective Prevotella genus with that of potential pathogens such as Escherichia/Shigella. Similarly, there are also positive correlations within these two phenotypic subgroupings, such that obligate anaerobic genera such as Prevotella, Roseburia, and Dialister are correlated with each other, while facultative anaerobic or microaerophilic genera such as Streptococcus, Lactobacillus, Escherichia/Shigella, and other Proteobacteria are also correlated with each other. The diarrhea-free network appears to be more tightly connected than the diarrheal network, consistent with ecological theories that equate environment diversity and connectedness with ecosystem stability/health [19, 20]. At the same time, we would like to note that our data do not allow a reliable quantitative assessment of such phenomena due to the large level of inter-personal variation.
Our analysis of the 16S rRNA gene-based taxonomic profile of diarrheal and control stool samples has demonstrated a strong association between acute diarrheal disease and the overall taxonomic composition of the stool microbiota in young children from the developing world. We have identified statistically significant disease associations with several organisms already implicated in diarrheal disease, such as members of the Escherichia/Shigella genus and C. jejuni. In addition, we have uncovered an association with diarrheal disease for several organisms not widely believed to cause this disease, such as Streptococcus and Granulicatella. Streptococcal OTUs associated with disease primarily belong to either the Streptococcus pneumoniae/mitis group (indistinguishable within the 16S rRNA gene regions targeted by our study), which contains several important human pathogens, or the Streptococcus pasteurianus group. These results merit further exploration as recent studies provide evidence of Streptococcus-related diarrheal cases [21, 22]. It is important to stress that pathogenicity is only one of many possible explanations for these findings and the organisms associated with disease status may also either: (1) usually inhabit the upper GI tract and become apparent in diarrheal stool due to dislodging and reduced transit time during disease; (2) thrive in disturbed gut environments; (3) may be better able to persist/resist dislodgement during a diarrheal purge; or (4) a combination of pathogens may cause disease in these children . Prior evidence certainly suggests that facultative anaerobes (many of which we find associated with diarrhea) tend to flourish in a variety of perturbed gut environments, possibly because the reducing power of the microbiota is affected by the loss of obligate anaerobes following perturbation . Any causality would need to be demonstrated through further experimentation. At the same time, streptococci are also found in our study to be associated with more severe forms of diarrhea (dysentery), thereby strengthening the case for a possible causal connection. Despite uncertainty regarding the causes and effects of microbiota perturbations in the setting of MSD, dissecting the physiologic implications is warranted. For example, an increase in streptococcal or other species in the setting of diarrhea may confer or exacerbate diarrheal effects. S. mutans has recently been postulated to have a role in human enteritis. Our work represents an important first step in understanding the complex interaction between microbiota and diarrheal pathogens in developing country settings.
Our study has also revealed a high prevalence of members of the Prevotella genus (primarily Prevotella copri) in the stool of developing world children, as well as the negative correlation of this genus with disease. These organisms are prevalent in the developing world , yet are relatively poorly studied due to fairly low prevalence in the industrialized world . Samples containing high proportions of members of the Prevotella genus also have higher overall bacterial diversity, potentially driven by the level of complex polysaccharides/starchy fiber in the diet. Recent evidence suggests that Prevotella spp. are particularly abundant in rural African children consuming a high fiber diet . This is in stark contrast to Western children, who typically have much higher abundances of Bacteroides spp., and very little Prevotella, a difference that is believed to be linked to diet .
Our co-occurrence network analyses (Additional file 3: Figure S7) and proportional abundance analysis (Additional file 1: Table S1) suggest potential negative interactions between Prevotella and enteric pathogens, such as members of the Escherichia/Shigella genus, raising the possibility for the development of novel Prevotella-based therapeutic strategies. Another possible probiotic organism identified in our study is Lactobacillus ruminis. This organism was found to be associated with non-diarrheal stool and also with less severe forms of diarrhea when comparing diarrheal to dysenteric stool. Although the increase in frequency of these taxa in diarrhea could be due to shortened intestinal transit time, the difference in prevalence of Lactobacillus between cases of MSD and dysentery are less likely to represent this effect. Lactobacillus ruminis has immunomodulatory properties and has been previously suggested as a potential probiotic .
Among OTUs found associated with non-diarrheal stool are sequences classified as Clostridum difficile, a surprising finding given that this organism is a common cause of enteric disease, primarily in hospitalized elderly patients. However, although C. difficile can be an important pathogen, it is actually carried asymptomatically by around 60% of infants . We also found a conflicting association of OTUs assigned as Bacteroides fragilis with both the diarrhea-free status and dysentery, a finding that can perhaps be explained by strain-to-strain variation. Enterotoxigenic B. fragilis strains are well characterized diarrheal agents in children  whereas, in contrast, non-toxigenic B. fragilis has been linked to anti-inflammatory protective effects in mouse models . It is therefore possible that different strains, which cannot be differentiated through 16S rRNA gene sequencing, might account for these opposing results.
Our study identified many sequences that do not have good matches against cultured organisms in current 16S rRNA gene databases. Many of these sequences only have high-quality matches to other uncultivated and uncharacterized intestinal microbes, highlighting the presence of a large reservoir of uncharacterized microbes in the intestinal tract of children within the developing world, as reported before . Many of the unknown sequences appear to belong to obligate anaerobic lineages of the Firmicutes phylum, which are under-represented in culture collections compared to other intestinal dwelling groups such as Bacteroides and bifidobacteria. The prevalence of such ‘unknown’ sequences is higher in controls and several of these uncharacterized organisms exhibit strong associations with diarrhea-free samples, highlighting their potential role in the maintenance of a healthy gut microbiota, and suggesting the need for a better in-depth characterization of the gut microbiota of children within the developing world, complementing resources recently developed in Europe  and the US .
Our observations related to the microbial succession in the developing infant gut microbiota carry several caveats. A single sample was collected from each child at a single point in time, and we lack extensive data on prior history of diarrhea. While the data are suggestive of a progression in microbiota structure, monitoring of a birth cohort will be necessary to fully understand the progression of gut microbiota, and assess the impact of diarrhea (including, potentially, multiple episodes of diarrhea) on this process. At a technical level, we would also note that the primer sets used in this study (targeting the V1-V2 hypervariable regions of the 16S rRNA gene) do not effectively amplify bifidobacteria [34, 35], known to be dominant members of the intestinal microbiota of breast-fed infants, but this bias is likely to be uniform between cases and controls. We purposefully selected a primer set better targeted towards bacterial groups containing known and potential pathogens, such as Enterobacteriaceae, to improve our chances of detecting novel pathogens at the cost of obtaining less information about the already well-established early dominance by bifidobacteria.
Our study revealed the limitations of existing molecular and bioinformatics approaches employed in a clinical setting for performing taxonomic surveys of stool samples. The use of the 16S rRNA gene, for example, does not afford a sufficient discrimination within taxonomic groups containing known or putative pathogens (Escherichia/Shigella, Streptococcus, and so on) indicating the pressing need for the development of new cost-effective and relatively unbiased molecular approaches  for increasing the resolution of epidemiological surveys such as ours. Relatedly, the accurate taxonomic assignment of sequences generated in studies such as ours is hampered by numerous errors in public databases and by the use of simplistic ‘lowest common ancestor’ heuristics by software tools faced with ambiguous taxonomic information. The results presented in this paper were obtained through the careful manual annotation of all the OTUs found to be associated with disease state (see Additional file 5: Table S4). Finally, we had to develop a novel statistical method  for identifying disease association in order to appropriately address data rarefaction as well as to control for the high inter-personal variability, a typical feature of the healthy gut microbiota , and other confounding factors.
Overall our study demonstrates that the major differences in the microbiota between diarrheal and normal stools are quantitative differences in the proportions of the most prevalent taxa. Such quantitative differences were also observed in our previous qPCR-based study where we found that 80% (1,665/2,072) of controls and 89% (1,307/1,461) of MSD cases had detectable levels of Shigella. Quantitative measurements of Shigella abundance were critical to assessing attributable risk . Among the known causes of diarrhea (rotavirus, Shigella, Cryptosporidium, Enterotoxigenic E. coli, and so on) the attributable fraction of diarrhea in young children is estimated to be just 43% . Our study provides initial evidence for the existence of novel pathogenic agents. The most likely candidates from our study are members of the Enterobacteriaceae and streptococci, taxa which already contain many known human pathogens. Further exploration of these organisms is necessary to better understand their pathogenic potential and the likelihood of their emergence as major pathogens through the acquisition of additional pathogenicity factors. Importantly, our study reveals a possible protective role against diarrhea for the Prevotella genus and Lactobacillus ruminis. Understanding such effect is important. For example, microbiological  or dietary  interventions may be possible in the supportive treatment of diarrhea in children similar to approaches used in the management of enteric infections in adults [39–41]. Further genomic and epidemiological studies are necessary to better characterize this genus and to assess the potential development of diet- or microbiological-based therapeutics.
Materials and methods
Study design and participants
Stool samples were selected from a large case/control study of moderate-to-severe diarrhea in children aged under 5 years . Cases were enrolled upon presentation to a health clinic reporting MSD. MSD eligibility criteria included sunken eyes, loss of normal skin turgor, a decision to initiate intravenous hydration or to hospitalize the child, or the presence of blood in the stool. Controls were sought following case enrollment, sampled from a demographic surveillance database of the area. Individuals were excluded if they were unable to produce a sufficient amount of stool volume for testing or they were unable or unwilling to consent to involvement in the study. Every participant was consented prior to collection of their stool and their data. Consent was given by the caregiver (usually mother) because the patients are all children aged less than 5 years. All samples were collected between March of 2008 and June of 2009. One sample was collected for each child and no time-series analyses were conducted. The Institutional Review Boards (IRBs) at all cooperating institutions have reviewed and approved the protocol. The IRB Federal Wide Assurance numbers for all the sites are as follows: University of Maryland Baltimore FWA00007145, The Gambia, Medical Research Council Labs FWA 00006873, Kenya Medical Research Institute FWA 00002066, University of Mali Faculty of Medicine Pharmacy and Dentistry FWA 00001769, and International Centre for Diarrhoeal Disease Research, Bangladesh FWA 00001468. Further details on study design are described by Kotloff et al..
Stool specimens were collected in sterile containers and examined within 24 h. Stools were stored at 2 to 8°C while in transit to the laboratory. Each fresh stool specimen was aliquoted into multiple tubes. All samples were analyzed by traditional microbiological tests for known bacterial, viral, and eukaryotic pathogens. Details of these methods can be found in Panchalingam et al.  DNA was isolated using a bead beater with 3 mm diameter solid glass beads (sigma Life Science), and subsequently 0.1 mm zirconium beads (BIO-SPEC Inc.) to disrupt cells. The cell slurry was then centrifuged at 16,000 g for 1 min, the supernatant removed and processed using the Qiagen QIAamp® DNA stool extraction kit. Extracted DNA was precipitated with 3 M sodium acetate and ethanol and the DNA shipped to the USA.
Amplification and sequencing
DNA was amplified using ‘universal’ primers targeting the V1-V2 region of the 16S rRNA gene (small subunit of the ribosome) in bacteria (338R (5’- CATGCTGCCTCCCGTAGGAGT-3’ and 27 F (5’-AGAGTTTGATCCTGGCTCAG-3’). Both forward and reverse primers had a 5’ portion specific for use with 454 FLX sequencing technology and the forward primers contained a barcode between the FLX and gene specific region, so that samples could be pooled to a multiplex level of 96 samples per instrument run (see Additional file 6: Table S5 for barcode information).
Sequencing data and sample metadata are available at the NCBI archive under project PRJNA234437.
Source code and documentation for the analysis pipeline are available at GitHub: .
Additional information on the study as well as links to all resources outlined above are made available at .
The individual reads were filtered for quality using custom in-house scripts that perform the following checks suggested in Huse et al.: (1) sequences containing any ambiguity codes (N) are removed; (2) sequences that were shorter than 75 cycles of the 454 instrument were removed (each cycle yields an average of 2.5 bp depending on the sequence composition); (3) sequences for which a barcode could not be identified were removed. These checks are similar to those that can be performed by Mothur . The high quality sequences were separated into 992 sample-specific sets according to the multiplexing barcodes. Conservative OTUs were clustered using DNAclust  with parameters (-r 1) (99% identity radius) thus ensuring that the definition of an OTU is consistent across all samples. To obtain taxonomic identification, a representative sequence from each OTU was aligned to Ribosomal Database (RDP)  (rdp.cme.msu.edu, release 10.4) using blastn with long word length (-W 100) in order to only detect nearly identical sequences. Sequences without a nearly identical match to RDP (>100 bp perfect match and >97% identity, as defined by BLAST) were marked as being ‘unassigned’ and assigned an OTU identifier. The resulting data were organized into a collection of tables at several taxonomic levels containing each taxonomic group as a row and each sample as a column.
We note that the clustering criteria we use (<2% divergence, including insertions and deletions) are more conservative than commonly used definitions of ‘species-level’ OTUs (<2% divergence excluding indels). We used conservative clustering because no universal cutoff applies to all organisms  and in order to avoid merging together organisms with potentially different phenotypes (for example, closely-related strains, see Additional file 3: Figure S4 for an example in closely-related Escherichia/Shigella OTUs). Similar considerations have led to the development of specialized software for the analysis of vaginal 16S rRNA gene survey data . Our approach provides a good tradeoff between mitigating the effect of errors and allowing an unbiased analysis of the data. Furthermore, an exploration of increasingly permissive clustering thresholds reveals that our conservative clustering strategy does not lose statistical power (see Additional file 3: Figures S5, S6).
Chimera checking was performed with Uchime 4.2.40 .
The most abundant 6879 OTUs were reprocessed using QIIME  version 1.8.0-dev as recommended on the PICRUST website (specifically OTUs were constructed with the pick_closed_reference_otus.py script against the latest version (version 13.5) of the Greengenes  database) and the resulting information was processed with PICRUST  version 1.0.0-dev using the KEGG analysis module and aggregating the results to level 3. The results were further explored with STAMP  version 2.0.2, using the two-group analysis module, focusing on known aerobic and anaerobic pathways.
In order to avoid the bias that may be introduced by preferential amplification or sequencing of specific sequences, we scaled the counts by the 56th percentile of the number of OTUs in each sample. The 56th percentile was empirically determined from the distribution of non-zero counts required to behave consistently across our samples. We normalized with a Cumulative Sum Scaling approach, which scales counts by dividing the sum of each sample’s counts up to and including the pth quantile (that is, for all samples j, S p = ∑ i (c ij |c ij ) ≤ q pj , where q pj is the pth quantile of sample j). Normalized counts are then given by . This method constrains communities with respect to a total size, but does not place undue influence on features (OTUs) that are preferentially sampled. A full description of the methodology is provided in Paulson et al. .
To test for presence and absence of an organism we performed Fisher’s test stratifying by positive and negative samples. Samples were stratified as positive for an organism if the sample had one or more sequences of the organism with a sample being negative if there was absence of sequences. The totals were calculated for each taxa, a minimum of 20 positive samples was required for a statistical test to be attempted. To correct for multiple comparisons we minimized the expected proportion of false positives following Benjamini and Hochberg .
Differential abundance was assessed with the package metagenomeSeq  - a statistical approach that models confounding such as age and country, and also the effect of undersampling on the observed counts. Significant findings were reported for OTUs that satisfied the following criteria: (1) OTU was abundant (≥12 normalized counts per sample) in cases or controls; (2) OTU was prevalent (present in ≥10 cases and controls); (3) OTU had fold change or odds ratio exceeding 2 in either cases or controls; and (4) statistical association was significant (P <0.05) after Benjamini-Hochberg correction for multiple testing.
Analyses were performed using the R software package 3.0.1 and packages, Vegan 2.0-7 and metagenomeSeq 1.2.21.
Correlation network construction
Correlation networks were constructed separately on cases and controls to characterize the dependencies between 268 differentially abundant OTUs (Additional file 4: Table S3).
Each network was built using SparCC , a tool specifically developed for assessing the correlation structure within microbial communities. The statistical significance for each OTU-OTU-interaction was obtained with an empirical null distribution using 1,000 bootstrap iterations. The P values were further adjusted for multiple comparisons using the Benjamini and Hochberg  correction. All OTU-OTU-interactions with FDR < =0.05, were considered significant and were represented as edges in the network.
For simplicity of visual representation, OTUs were aggregated at genus or lower taxonomic levels using the median normalized abundance of the aggregated OTUs as the abundance of the corresponding taxonomic group. We omitted all taxonomic groups with median abundance lower than 500 normalized counts, as well as all edges with SparCC correlation lower than 0.09. The plots were drawn in Cytoscape 3.0.1 .
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, et al: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012, 380: 2095-2128. 10.1016/S0140-6736(12)61728-0.
Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, Jha P, Campbell H, Walker CF, Cibulskis R, Eisele T, Liu L, Mathers C, Child Health Epidemiology Reference Group of WHO and UNICEF: Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010, 375: 1969-1987. 10.1016/S0140-6736(10)60549-1.
Walker CL, Aryee MJ, Boschi-Pinto C, Black RE: Estimating diarrhea mortality among young children in low and middle income countries. PLoS One. 2012, 7: e29151-10.1371/journal.pone.0029151.
Levine MM, Kotloff KL, Nataro JP, Muhsen K: The Global Enteric Multicenter Study (GEMS): impetus, rationale, and genesis. Clin Infect Dis. 2012, 55: S215-S224. 10.1093/cid/cis761.
Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, Faruque AS, Zaidi AK, Saha D, Alonso PL, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ochieng JB, Omore R, Oundo JO, Hossain A, Das SK, Ahmed S, Qureshi S, Quadri F, Adegbola RA, Antonio M, et al: Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case–control study. Lancet. 2013, 382: 209-222. 10.1016/S0140-6736(13)60844-2.
Ghodsi M, Liu B, Pop M: DNACLUST: accurate and efficient clustering of phylogenetic marker genes. BMC Bioinformatics. 2011, 12: 271-10.1186/1471-2105-12-271.
Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R: QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010, 7: 335-336. 10.1038/nmeth.f.303.
Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO: Development of the human infant intestinal microbiota. PLoS Biol. 2007, 5: e177-10.1371/journal.pbio.0050177.
Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, Angenent LT, Ley RE: Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A. 2011, 108: 4578-4585. 10.1073/pnas.1000081107.
Mackie RI, Sghir A, Gaskins HR: Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr. 1999, 69: 1035s-1045s.
Cebra JJ: Influences of microbiota on intestinal immune system development. Am J Clin Nutr. 1999, 69: 1046S-1051S.
Sjogren YM, Tomicic S, Lundberg A, Bottcher MF, Bjorksten B, Sverremark-Ekstrom E, Jenmalm MC: Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses. Clin Exp Allergy. 2009, 39: 1842-1851. 10.1111/j.1365-2222.2009.03326.x.
Rajilic-Stojanovic M, Smidt H, de Vos WM: Diversity of the human gastrointestinal tract microbiota revisited. Environ Microbiol. 2007, 9: 2125-2136. 10.1111/j.1462-2920.2007.01369.x.
Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP, Heath AC, Warner B, Reeder J, Kuczynski J, Caporaso JG, Lozupone CA, Lauber C, Clemente JC, Knights D, Knight R, Gordon JI: Human gut microbiome viewed across age and geography. Nature. 2012, 486: 222-227.
Walker AW, Lawley TD: Therapeutic modulation of intestinal dysbiosis. Pharmacol Res. 2013, 69: 75-86. 10.1016/j.phrs.2012.09.008.
Langille MGI, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Vega Thurber RL, Knight R, Beiko RG, Huttenhower C: Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotech. 2013, 31: 814-821. 10.1038/nbt.2676.
Parks DH, Beiko RG: Identifying biologically relevant differences between metagenomic communities. Bioinformatics. 2010, 26: 715-721. 10.1093/bioinformatics/btq041.
Paulson JN, Stine OC, Bravo HC, Pop M: Differential abundance analysis for microbial marker-gene surveys. Nat Methods. 2013, 10: 1200-1202. 10.1038/nmeth.2658.
Girvan MS, Campbell CD, Killham K, Prosser JI, Glover LA: Bacterial diversity promotes community stability and functional resilience after perturbation. Environ Microbiol. 2005, 7: 301-313. 10.1111/j.1462-2920.2005.00695.x.
McCann KS: The diversity-stability debate. Nature. 2000, 405: 228-233. 10.1038/35012234.
Shields TM, Chen KD, Gould JM: Pediatric Case Report of Chronic Colitis Associated With an Unusual Serotype of Streptococcus pneumoniae. Infectious Diseases in Clinical Practice. 2012, 20: 357-358. 10.1097/IPC.0b013e318248f122.
Jin D, Chen C, Li L, Lu S, Li Z, Zhou Z, Jing H, Xu Y, Du P, Wang H, Xiong Y, Zheng H, Bai X, Sun H, Wang L, Ye C, Gottschalk M, Xu J: Dynamics of fecal microbial communities in children with diarrhea of unknown etiology and genomic analysis of associated Streptococcus lutetiensis. BMC Microbiol. 2013, 13: 141-10.1186/1471-2180-13-141.
Taniuchi M, Sobuz SU, Begum S, Platts-Mills JA, Liu J, Yang Z, Wang XQ, Petri WA, Haque R, Houpt ER: Etiology of diarrhea in bangladeshi infants in the first year of life analyzed using molecular methods. J Infect Dis. 2013, 208: 1794-1802. 10.1093/infdis/jit507.
Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poultain J, Qin J, Sicheritz-Ponten T, Tims S, et al: Enterotypes of the human gut microbiome. Nature. 2011, 473: 174-180. 10.1038/nature09944.
De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G, Lionetti P: Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 2010, 107: 14691-14696. 10.1073/pnas.1005963107.
Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, Sinha R, Gilroy E, Gupta K, Baldassano R, Nessel L, Li H, Bushman FD, Lewis JD: Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011, 334: 105-108. 10.1126/science.1208344.
Taweechotipatr M, Iyer C, Spinler JK, Versalovic J, Tumwasorn S: Lactobacillus saerimneri and Lactobacillus ruminis: novel human-derived probiotic strains with immunomodulatory activities. FEMS Microbiol Lett. 2009, 293: 65-72. 10.1111/j.1574-6968.2009.01506.x.
Jangi S, Lamont JT: Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J Pediatr Gastroenterol Nutr. 2010, 51: 2-7. 10.1097/MPG.0b013e3181d29767.
Sears CL, Myers LL, Lazenby A, Van Tassell RL: Enterotoxigenic Bacteroides fragilis. Clin Infect Dis. 1995, 20: S142-S148. 10.1093/clinids/20.Supplement_2.S142.
Mazmanian SK, Round JL, Kasper DL: A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 2008, 453: 620-625. 10.1038/nature07008.
Lin A, Bik EM, Costello EK, Dethlefsen L, Haque R, Relman DA, Singh U: Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States. PLoS One. 2013, 8: e53838-10.1371/journal.pone.0053838.
Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, et al: A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010, 464: 59-65. 10.1038/nature08821.
Human Microbiome Project Consortium: A framework for human microbiome research. Nature. 2012, 486: 215-221. 10.1038/nature11209.
Sim K, Cox MJ, Wopereis H, Martin R, Knol J, Li MS, Cookson WO, Moffatt MF, Kroll JS: Improved detection of bifidobacteria with optimised 16S rRNA-gene based pyrosequencing. PLoS One. 2012, 7: e32543-10.1371/journal.pone.0032543.
Frank JA, Reich CI, Sharma S, Weisbaum JS, Wilson BA, Olsen GJ: Critical evaluation of two primers commonly used for amplification of bacterial 16S rRNA genes. Appl Environ Microbiol. 2008, 74: 2461-2470. 10.1128/AEM.02272-07.
Lindsay B, Pop M, Antonio M, Walker AW, Mai V, Ahmed D, Oundo J, Tamboura B, Panchalingam S, Levine MM, Kotloff K, Li S, Magder LS, Paulson JN, Liu B, Ikumapayi U, Ebruke C, Dione M, Adeyemi M, Rance R, Stares MD, Ukhanova M, Barnes B, Lewis I, Ahmed F, Alam MT, Amin R, Siddiqui S, Ochieng JB, Ouma E, et al: Survey of culture, goldengate assay, universal biosensor assay, and 16S rRNA Gene sequencing as alternative methods of bacterial pathogen detection. J Clin Microbiol. 2013, 51: 3263-3269. 10.1128/JCM.01342-13.
Lay C, Rigottier-Gois L, Holmstrom K, Rajilic M, Vaughan EE, de Vos WM, Collins MD, Thiel R, Namsolleck P, Blaut M, Dore J: Colonic microbiota signatures across five northern European countries. Appl Environ Microbiol. 2005, 71: 4153-4155. 10.1128/AEM.71.7.4153-4155.2005.
Lindsay B, Ochieng JB, Ikumapayi UN, Toure A, Ahmed D, Li S, Panchalingam S, Levine MM, Kotloff K, Rasko DA, Morris CR, Juma J, Fields BS, Dione M, Malle D, Becker SM, Houpt ER, Nataro JP, Sommerfelt H, Pop M, Oundo J, Antonio M, Hossain A, Tamboura B, Stine OC: Quantitative PCR for detection of shigella improves ascertainment of shigella burden in children with moderate-to-severe diarrhea in low-income countries. J Clin Microbiol. 2013, 51: 1740-1746. 10.1128/JCM.02713-12.
Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, Raisen C, Goulding D, Rad R, Schreiber F, Brandt C, Deakin LJ, Pickard DJ, Duncan SH, Flint HJ, Clark TG, Parkhill J, Dougan G: Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 2012, 8: e1002995-10.1371/journal.ppat.1002995.
Ubeda C, Bucci V, Caballero S, Djukovic A, Toussaint NC, Equinda M, Lipuma L, Ling L, Gobourne A, No D, Taur Y, Jeng RR, van den Brink MR, Xavier JB, Pamer EG: Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect Immun. 2013, 81: 965-973. 10.1128/IAI.01197-12.
Senior K: Faecal transplantation for recurrent C difficile diarrhoea. Lancet Infect Dis. 2013, 13: 200-201. 10.1016/S1473-3099(13)70052-5.
Kotloff KL, Blackwelder WC, Nasrin D, Nataro JP, Farag TH, van Eijk A, Adegbola RA, Alonso PL, Breiman RF, Faruque AS, Saha D, Sow SO, Sur D, Zaidi AK, Biswas K, Panchalingam S, Clemens JD, Cohen D, Glass RI, Mintz ED, Sommerfelt H, Levine MM: The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study. Clin Infect Dis. 2012, 55: S232-S245. 10.1093/cid/cis753.
Panchalingam S, Antonio M, Hossain A, Mandomando I, Ochieng B, Oundo J, Ramamurthy T, Tamboura B, Zaidi AK, Petri W, Houpt E, Murray P, Prado V, Vidal R, Steele D, Strockbine N, Sansonetti P, Glass RI, Robins-Browne RM, Tauschek M, Svennerholm AM, Berkeley LY, Kotloff K, Levine MM, Nataro JP: Diagnostic microbiologic methods in the GEMS-1 case/control study. Clin Infect Dis. 2012, 55: S294-S302. 10.1093/cid/cis754.
Analysis pipeline for GEMS pathogen discovery project. https://github.com/MihaiPop/GEMS-db,
McDonald D, Clemente JC, Kuczynski J, Rideout JR, Stombaugh J, Wendel D, Wilke A, Huse S, Hufnagle J, Meyer F, Knight R, Caporaso JG: The Biological Observation Matrix (BIOM) format or: how I learned to stop worrying and love the ome-ome. Gigascience. 2012, 1: 7-10.1186/2047-217X-1-7.
Data generated in GEMS pathogen discovery project. http://www.cbcb.umd.edu/datasets/gems-study-diarrheal-disease,
GEMS pathogen discovery project: summary page. http://www.cbcb.umd.edu/research/projects/GEMS-pathogen-discovery,
Huse SM, Huber JA, Morrison HG, Sogin ML, Welch DM: Accuracy and quality of massively parallel DNA pyrosequencing. Genome Biol. 2007, 8: R143-10.1186/gb-2007-8-7-r143.
Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, Sahl JW, Stres B, Thallinger GG, Van Horn DJ, Weber CF: Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009, 75: 7537-7541. 10.1128/AEM.01541-09.
Cole JR, Chai B, Farris RJ, Wang Q, Kulam SA, McGarrell DM, Garrity GM, Tiedje JM: The Ribosomal Database Project (RDP-II): sequences and tools for high-throughput rRNA analysis. Nucleic Acids Res. 2005, 33: D294-D296.
White JR, Navlakha S, Nagarajan N, Ghodsi MR, Kingsford C, Pop M: Alignment and clustering of phylogenetic markers–implications for microbial diversity studies. BMC Bioinformatics. 2010, 11: 152-10.1186/1471-2105-11-152.
Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, Karlebach S, Gorle R, Russell J, Tacket CO, Brotman RM, Davis CC, Ault K, Peralta L, Forney LJ: Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2011, 108: 4680-4687. 10.1073/pnas.1002611107.
Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R: UCHIME improves sensitivity and speed of chimera detection. Bioinformatics. 2011, 27: 2194-2200. 10.1093/bioinformatics/btr381.
DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, Huber T, Dalevi D, Hu P, Andersen GL: Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006, 72: 5069-5072. 10.1128/AEM.03006-05.
Benjamini Y, Hockberg Y: Controlling the false discovery rate - a practical and powerful approach to multiple testing. J Roy Stat Soc B Met. 1995, 57: 289-300.
Friedman J, Alm EJ: Inferring correlation networks from genomic survey data. PLoS Comput Biol. 2012, 8: e1002687-10.1371/journal.pcbi.1002687.
Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, Workman C, Christmas R, Avila-Campilo I, Creech M, Gross B, Hanspers K, Isserlin R, Kelley R, Killcoyne S, Lotia S, Maere S, Morris J, Ono K, Pavlovic V, Pico AR, Vailaya A, Wang PL, Adler A, Conklin BR, Hood L, Kuiper M, Sander C, Schmulevich I, Schwikowski B, Warner GJ, et al: Integration of biological networks and gene expression data using Cytoscape. Nat Protoc. 2007, 2: 2366-2382. 10.1038/nprot.2007.324.
This work was funded in part by the William and Melinda Gates Foundation, award 42917 to JPN and OCS; US National Institutes of Health grants 5R01HG005220 to HCB, 5R01HG004885 to MP; US National Science Foundation Graduate Research Fellowship award DGE0750616 to JNP; AWW and JP are funded by The Wellcome Trust (Grant No. WT098051).
The authors declare that they have no competing interests.
Sample collection and data management: MP, BRL, MA, MAH, JO, BT, MML, SP, KK, UNI, CE, MA, DA, FA, MTA, RA, SS, JBO, EO, JJ, EU, RO. 16S rRNA gene data collection and analysis: MP, AWW, JNP, BRL, VM, IA, HCB, RR, MDS, VM, JP, JPN, OCS. Study design: MP, AWW, MA, MAH, JO, VM, MML, RFB, JGM, DS, JP, OCS, JPN. Statistical analysis: MP, AWW, JNP, BL, IA, HCB, OCS. Writing: MP, AWW, JNP, BL, JPN, OCS. All authors read and approved the final manuscript.
Electronic supplementary material
Additional file 5: Table S4: Mapping of taxonomic names used in our paper and nearest hits to the corresponding 16S rRNA sequence. Due to the poor resolution of the 16S rRNA region used in our study we manually assigned each OTU to the most precise taxonomic level possible. In some cases a same organism appears in multiple groups, reflecting errors in the underlying database used (RDP version 10.4). For brevity, only ambiguous taxonomic groups are listed. (DOCX 13 KB)
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
Pop, M., Walker, A.W., Paulson, J. et al. Diarrhea in young children from low-income countries leads to large-scale alterations in intestinal microbiota composition. Genome Biol 15, R76 (2014) doi:10.1186/gb-2014-15-6-r76
- Intestinal Microbiota
- Diarrheal Disease
- Ribosomal Database Project
- Microbiota Composition